Biocon subsidiary secures FDA approval for critical blood pressure medication
Biocon Pharma Limited receives FDA approval for Norepinephrine Bitartrate Injection USP, expanding its complex drug portfolio ...
Medical Dialogues19h
Biocon Pharma gets USFDA approval for BP-raising injection in adults with acute hypotension
Bengaluru: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval ...
Drug Store News12h
Biocon Pharma gets FDA nod for norepinephrine bitartrate injection
Norepinephrine bitartrate injection is indicated to raise blood pressure in adult patients with acute hypotension.
CNBCTV1819h
Biocon unit gets USFDA nod for blood pressure treatment drug
Norepinephrine bitartrate injection is a critical medication used to raise blood pressure in adult patients suffering from ...
The Independent Singapore News5d
Johor to become Asia’s largest insulin hub with Biocon’s RM2.7B investment; expansion to create over 300 high-skilled jobs
Johor is set to become Asia's largest insulin hub as India's leading biotechnology firm, Biocon Ltd, invests another RM1.1 ...
Yahoo Finance28d
Biocon Biologics Launches Yesintek™ (ustekinumab-kfce) Biosimilar to Stelara® in the United States
BRIDGEWATER, N.J. and BENGALURU, India, Feb. 24, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code ...
Yahoo Finance17d
Biocon Biologics Announces Positive Results from Phase 3 Study of Yesintek™ Biosimilar to Ustekinumab for Chronic Plaque Psoriasis
BRIDGEWATER, N.J., and BENGALURU, India, March 7, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code ...
Biocon shares in focus after successful results of Yesintek in Phase 3
Biocon's shares have risen by 18.31% over the past year. However, year-to-date (YTD), the stock has dropped by 9.59%. In the last six months, it has decreased by 10.84%, while the stock fell by 12.23% ...
Wall Street Journal4d
Biocon Ltd.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...